Basappa NS. Treatment options in advanced renal cell carcinoma after first-line treatment with vascular endothelial growth factor receptor tyrosine kinase inhibitors. CUAJ [Internet]. 2016 Dec. 15 [cited 2024 Apr. 25];10(11-12):S242-4. Available from: https://cuaj.ca/index.php/journal/article/view/4292